BGPT: Paper Review: Pathophysiology of sepsis-induced myocardial dysfunction

Explore by Goal

Quick Explanation Copied

Paper focus:

Sepsis-induced myocardial dysfunction (SIMD) is framed as intrinsic biventricular systolic + diastolic impairment that EF often fails to detect because EF is load-dependent, and multiple immuno-metabolic and neurohumoral mechanisms are proposed (TLR/MyD88→NF-κB/JNK/ERK/p38; Ca²⁺ handling defects; fatty-acid oxidation/PPAR repression; mitochondrial dysfunction; apoptosis; endothelial/fibroblast contributions).

Key review: 10.1186/s40779-016-0099-9

Long Explanation

BGPT Visual Paper Review

“Pathophysiology of sepsis-induced myocardial dysfunction” (Narrative review) • DOI: 10.1186/s40779-016-0099-9

Fast scaffold

(1) Definition & measurement pitfalls → (2) Clinical phenotypes → (3) Biomarkers → (4) Core mechanisms → (5) What remains uncertain

Figure 1. “Myocardial depressant factors” categories (from the paper’s Table 1)

Count logic: factors are enumerated directly from the review’s Table 1 rows.

Figure 2. Mechanism map (review-internal causal graph)

This is a review-derived map, not a verified mechanistic model.

Causal blocks summarized from the review text include: TLR/MyD88-driven inflammatory signaling (NF-κB/JNK/ERK1/2/p38) leading to cytokine production; proposed contributions from Ca²⁺ handling defects; energy mismanagement via reduced fatty-acid oxidation/PPAR-related signaling; mitochondrial dysfunction/oxidative-nitrosative stress; autonomic dysregulation; endothelial and fibroblast involvement; and apoptosis.

Figure 3. Diagnostic tension: EF vs intrinsic function (load-dependence claim)

The review argues EF may be misleading because it is load-dependent, and suggests load-independent approaches can better reflect intrinsic systolic/diastolic dysfunction.

Important: This figure is intentionally conceptual (not a quantified meta-analysis). The underlying point—that EF can be normal when afterload is depressed even if intrinsic contractility is impaired—is a central claim of the review.

Figure 4. Review’s ‘SIMD definition’ in one line

SIMD = intrinsic biventricular systolic + diastolic dysfunction induced by sepsis (not reliably captured by EF alone).

Long analysis (VISUALS → EXPLANATION)

1) What the paper says is “known” vs “uncertain”

Known/strongly emphasized: There is no universally accepted definition; EF is load-dependent and can mask intrinsic impairment; the review argues for incorporating systolic + diastolic dysfunction concepts and load-independent imaging/physiology where possible.
Uncertain/needs better evidence: Translational causality between specific circulating factors (e.g., cytokines) and measured intrinsic dysfunction is repeatedly presented as plausible but not always corroborated (e.g., inconsistent correlations in clinical data are discussed).

2) Clinical phenotyping: why “warm vs cold shock” doesn’t resolve cardiac mechanisms

The review recounts the hemodynamic split into hyperdynamic (“warm shock”) and hypodynamic (“cold shock”) phases, but emphasizes that older markers used in this logic (e.g., central venous pressure as a proxy) may be inadequate to disentangle intrinsic myocardial dysfunction from changes in preload/afterload/neurohumoral tone.

3) Mechanistic core: immuno-inflammation, immunometabolism, and neurohumoral control

The review’s mechanistic structure is multi-layered:

Innate immune receptor signaling: TLRs (except TLR3) signal through MyD88 to activate MAPKs (JNK/ERK1/2/p38) and NF-κB, inducing pro-inflammatory cytokines (IL-1, IL-6, TNF-α).
Damage-mediators: Proposed myocardial depressant factors include TNF-α, IL-1, IL-6, C5a, LPS, HMGB1, extracellular histones, and MMP-9 (Table 1).
Neurohumoral/adrenergic remodeling: The review proposes autonomic dysregulation with changes in β-adrenergic receptor density/signaling and upregulation of β3-adrenoceptors potentially contributing to negative inotropy.
Ca²⁺ handling: Downregulated L-type Ca²⁺ channels and suppressed SR Ca²⁺ pump plus impaired membrane Ca²⁺ extrusion pathways are described as contributors to disturbed Ca²⁺ homeostasis.
Energy mismanagement: The review emphasizes reduced fatty-acid uptake/FAO and repression of PPAR-linked energy programs, arguing that decreased FAO can reduce ATP production and contribute to dysfunction.
Mitochondria & oxidative-nitrosative stress: Late-stage downregulation of mitochondrial complexes and reduced ATP are described, alongside proposals that oxidative-nitrosative stress, permeability transition pore opening, and uncoupling are relevant.

4) Biomarkers & structural pathology: useful signals, but not a full causal key

The review surveys biomarkers including BNP/NT-proBNP, cardiac troponins, and heart-type fatty-acid binding protein, but also warns that diagnostic value depends on correctly linking biomarker change to intrinsic myocardial dysfunction rather than systemic stress.

5) Critical critique (skeptical, falsifiability-focused)

Narrative review risk: The paper synthesizes many studies but does not perform systematic quantitative meta-analysis; this increases sensitivity to selective emphasis across mechanisms. (This is a methodological critique of the review format itself, grounded in the fact that it reports literature synthesis with no new dataset.)
Measurement heterogeneity: Multiple clinical methods (EF, radionuclide ventriculography, echocardiographic strain, tissue Doppler diastolic indices) can yield different ‘dysfunction’ classifications because of load dependence and confounding by hemodynamics; the review explicitly treats this as a major reason for inconsistent clinical findings.
Mechanism–biomarker coupling is not guaranteed: The review highlights clinical findings where circulating cytokines did not correlate with measured systolic/diastolic dysfunction, suggesting that either (i) not all cytokines are the relevant drivers, (ii) local tissue gradients matter more than plasma levels, (iii) timing and compartmentalization are critical, or (iv) multiple pathways converge on dysfunction.
Reversibility is asserted but remains partly unresolved: The review discusses SIMD as thought to be reversible but explicitly notes uncertainty about whether histological changes are fully reversible in patients.

6) What information would most likely falsify/shift the review’s claims?

Clinical falsification target: If intrinsic systolic/diastolic dysfunction (using load-independent or combined approaches) is not consistently detected or does not track outcomes differently than global illness severity, the ‘SIMD as intrinsic disease entity’ framing weakens.
Mechanistic falsification target: If interventions targeting putative drivers (e.g., TLR/MyD88–NF-κB axis, FAO/PPAR repression, mitochondrial dysfunction, or Ca²⁺ handling defects) reliably fail to change the intrinsic dysfunction phenotype, causal hierarchy collapses into correlation-only territory.

Explore more on BGPT

Author reviews (BGPT)

Feedback:

Updated: April 19, 2026